Duration of nonresponse to noxious stimulation after intramuscular administration of butorphanol, medetomidine, or a butorphanol-medetomidine combination during isoflurane administration in dogs

Objective-To assess duration of actions of butorphanol, medetomidine, and a butorphanol-medetomidine combination in dogs given subanesthetic doses of isoflurane (ISO). Animals-6 healthy dogs. Procedure-Minimum alveolar concentration (MAC) Values for ISO were determin ed, for each dog. Subsequently, 4 treatments were administered to each dog (saline [0.9% NaCl] solution, butorphanol [0.2 mg/kg of body weight], medet omidine [5.0 mu g/kg], and a combination of butorphanol [0.2 mg/kg] and med etomidine [5.0 mu g/kg]). All treatments were administered IM to dogs concu rrent with isoflurane; treatment order was determined, using a randomized c rossover design. Treatments were given at 7-day intervals. After mask induc tion with ISO and instrumentation with a rectal temperature probe, end-tida l CO2 and anesthetic gas concentrations were analyzed. End-tidal ISO concen tration was reduced to 90% MAC for each dog. A tail clamp was applied 15 mi nutes later. After a positive response, 1 of the treatments was administere d. Response to application of the tail clamp was assessed at 15-minute inte rvals until a positive response again was detected. Results-Duration of nonresponse after administration of saline solution, bu torphanol, medetomidine, and butorphanol-medetomidine (mean +/- SD) was 0.0 +/- 0.0, 1.5 +/- 1.5, 2.63 +/- 0.49, and 5.58 +/- 2.28 hours, respectively . Medetomidine effects were evident significantly longer than those for sa line solution, whereas effects for bulorphanol-medetomidine were evident si gnificantly longer than for each agent administered alone. Conclusion and Clinical Relevance-During ISO-induced anesthesia, administra tion of medetomidine, but not butorphanol, provides longer and more consist ent analgesia than does saline solution, and the combination of butorphanol -medetomidine appears superior to the use of medetomidine or butorphanol al one.